Business The billion-dollar biotech
Jun 4, 2015, 00:00 AM
by
Michael Croft
Nature News & Comment | Moderna Therapeutics
has big ambitions and a bankroll to match. How a fledgling start-up
became one of the most highly valued private drug firms ever.
June 04, 2015 | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever. Nature News & Comment